SignalCorporate
Sartorius Stedim Biotech S.A. Non-GAAP EPS of €2.84, revenue of €2.29B
Sartorius Stedim Biotech reported non-GAAP EPS of €2.84 and revenue of €2.29B.
Context
What happened: Sartorius Stedim Biotech S.A. reported 9M Non-GAAP EPS of €2.84 and revenue of €2.29B, up 4.1% year over year. Management confirmed and partially refined its fiscal year 2026 guidance.
Key numbers: 9M Non-GAAP EPS €2.84; revenue €2.29B (+4.1% Y/Y); constant currency sales growth guidance around 6 to
Why it matters: Growth including intended customer compensation for U.S. tariffs is expected in the lower half of the range, while operational growth excluding tariff effects is expected near the midpoint. The capex ratio guidance was refined slightly below the prior-year level.
Coverage: 4 outlets in 24h
What changed
Sartorius Stedim Biotech S.A. reported 9M Non-GAAP EPS of €2.84 and revenue of €2.29B, up 4.1% year over year. Management confirmed and partially refined its fiscal year 2026 guidance.
Why it matters
Growth including intended customer compensation for U.S. tariffs is expected in the lower half of the range, while operational growth excluding tariff effects is expected near the midpoint. The capex ratio guidance was refined slightly below the prior-year level.